Practice Points in TGCT: Updates on Safe Use of Novel Systemic Options

0.25 hr(s) | ABIM , CME , MOC , Royal College of Physicians and Surgeons of Canada

Therapeutic Area(s): Oncology

Release Date: January 13, 2022

Expiration Date: January 12, 2023

Location: Internet Activity Enduring

Understanding practical considerations with systemic therapy in tenosynovial giant cell tumor (TGCT) can be critical for safe delivery of therapy. In this activity, an expert medical oncologist provides a practical update on targeted treatment options for TGCT management, with a focus on safe delivery of care—including appropriate dosing, food effects, and safety considerations—based on the current clinical experience with approved CSF1R inhibitors.

Access this activity
Share via
Copy link
Powered by Social Snap